Overview
Mark Shaw practices in East Melbourne, Australia. Mr. Shaw is rated as an Experienced expert by MediFind in the treatment of Newborn Low Blood Sugar. His top areas of expertise are Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Newborn Low Blood Sugar.
His clinical research consists of co-authoring 27 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Newborn Low Blood Sugar.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorMr. Shaw isExperienced. Learn about Bone Tumor.
- Low Blood SugarMr. Shaw isExperienced. Learn about Low Blood Sugar.
- Lung CancerMr. Shaw isExperienced. Learn about Lung Cancer.
- Newborn Low Blood SugarMr. Shaw isExperienced. Learn about Newborn Low Blood Sugar.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Shaw isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Renal Cell Carcinoma (RCC)Mr. Shaw isExperienced. Learn about Renal Cell Carcinoma (RCC).